Strategic Advocates »

Catalyst Pharmaceutical Partners shares owned by Strategic Advocates

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Strategic Advocates from 13F filings

Historical chart of Strategic Advocates investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Strategic Advocates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Strategic Advocates

Quarter filed Position value Share count Share price at filing
2024-03-31 $212k 13k 15.94

More positions owned by Strategic Advocates

Vanguard Intermediate-term Bond Etf Etf (BIV)
Spdr S&p Kensho New Economies Composite Etf Etf (KOMP)
Invesco Qqq Trust Series I Etf (QQQ)
Invesco S&p 500 Pure Value Etf Etf (RPV)
Vanguard Long-term Corporate Bond Etf Etf (VCLT)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard S&p Small-cap 600 Growth Etf Etf (VIOG)
Nvidia Corporation Stock (NVDA)
Pimco 0-5 Year High Yield Corporate Bond Index Exchange-traded Fund Pimco 0 Etf (HYS)
Apple Stock (AAPL)
Amazon Stock (AMZN)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Intuitive Surgical Stock (ISRG)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)

View all positions for Strategic Advocates

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Charles Schwab Investment Management
Goldman Sachs Group
LSV Asset Management
Bank of New York Mellon
Jupiter Asset Management

View all funds holding Catalyst Pharmaceutical Partners